However, the ratio between PTX3 and FGF2 decreases during the transition from MGUS to MM, leading to more abundant levels of FGF2 in these cells, representing a brake release mechanism to promote an angiogenic switch in MM [21]. The gene discussed is PTX3; the disease is Miyoshi myopathy.